Миелосупресия Лечението с Tasigna се свързва с (National Cancer Institute Common Toxicity Criteria степен 3- 4) тромбоцитопения, неутропения и анемия.
Myelosuppression Treatment with Tasigna is associated with (National Cancer Institute Common Toxicity Criteria grade 3-4) thrombocytopenia, neutropenia and anaemia.